MedTrace Logo

Treatment Reality of Tension Band Wiring and Locked Plate Fixation of the Olecranon

NCT06615999 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15705

Last updated 2024-09-27

No results posted yet for this study

Summary

The incidence of the olecranon fracture (OF) in adults is around 12 per 100,000 inhabitants per year.1 The anatomical shape of the proximal ulna is largely responsible for the stabilization of the humeroulnar joint and reconstruction is therefore obligatory, but often challenging. Surgical treatment of the olecranon fracture is performed using tension band wiring (TBW) or locking plate fixation (LPF) osteosynthesis. It is not yet clear, which procedure is superior for a specific patient. In future, an individualized and objectified assessment of expected general and fracture-specific complications should enable the treatment to be individually adapted to the patient\'s risk profile. This shall prevent complications, unnecessary treatments, and treatment costs. In the project presented here, the reality of care for surgically treated patients with olecranon fractures will be analyzed using routine data collected by the BARMER health insurance fund.

The aim of the study is to analyze differences in the outcome of patients with an olecranon fracture treated with TBW compared to LPF and to identify independent risk factors for unfavorable course.

Conditions

  • Olecranon Fracture

Interventions

PROCEDURE

Simple fracture Tension band wiring

OPS 5-793.27

PROCEDURE

Simple fracture locked plate fixation

OPS 5-793.k7

PROCEDURE

Multi-fragmented tension band wiring

OPS 5-794.17

PROCEDURE

Multi-fragmented locked plate fixation

OPS 5-794.k7

Sponsors & Collaborators

  • Universität Münster

    collaborator OTHER

  • University Hospital Muenster

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-01
Primary Completion
2023-09-30
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06615999 on ClinicalTrials.gov